Neurocrine Biosciences

Neurocrine

Pharma

Neurocrine's Prader-Willi med tied to possible safety concerns

A year and a half after the approval of Vykat XR, clinicians connected to the Prader-Willi syndrome community are flagging potential safety concerns.

Fraiser Kansteiner Aug 13, 2026 9:40am

Motion blurs of people hurrying around an office

Neurocrine data make case for timely movement disorder diagnosis

May 5, 2026 6:03am

A chessboard with blocks that read MA

Neurocrine pays $2.9B for Soleno, its largest M&A deal ever

Apr 6, 2026 10:30am

Lifeline

Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm

dart board miss failure

Neurocrine's Ingrezza misses in cerebral palsy trial

Dec 23, 2025 10:20am

Neurocrine Biosciences Carnie Wilson tardive dyskinesia campaign

Neurocrine taps Wilson Phillips star for tardive dyskinesia push

May 6, 2025 11:16am